The complex nature of cancer, based on different genetic foundations in each individual, requires personalized medicine and targeted treatment approaches. Advanced molecular techniques such as Next Generation Sequencing (NGS), digital PCR, and qPCR are revolutionizing the fight against cancer by decoding these personalized genetic codes. However, the success of these sensitive analyses relies on two fundamental pillars: First, obtaining the purest nucleic acid from the biological sample; second, using special synthetic oligonucleotides (primers and probes) that will analyze these nucleic acids with the highest sensitivity.
As Letgen Biotechnology, we offer world-leading solutions at every step of this critical research and development process. We enable you to obtain the highest quality starting material by combining Roche MagNa Pure’s fully automated and fast-resulting systems with Norgen Biotek’s superior purification technologies. In the analysis phase, we empower your studies with high-purity custom synthetic primers and probes produced by Microsynth, Switzerland’s leading oligonucleotide manufacturer with over 30 years of experience. We ensure you achieve the most reliable results in your analyses by combining these valuable components with the Roche LightCycler qPCR and dPCR device family, considered the gold standard for sensitivity in the PCR world. Discover our products to lay a solid foundation for your research from the very beginning.